Securian Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.33M Sell
154,244
-361
-0.2% -$9.61K 0.17% 82
2025
Q4
$3.85M Sell
154,605
-119,974
-44% -$3.03M 0.15% 96
2025
Q3
$7M Sell
274,579
-22,669
-8% -$560K 0.19% 93
2025
Q2
$7.21M Sell
297,248
-2,942
-1% -$68.6K 0.21% 88
2025
Q1
$7.61M Sell
300,190
-4,386
-1% -$115K 0.23% 78
2024
Q4
$8.08M Sell
304,576
-8,839
-3% -$240K 0.24% 73
2024
Q3
$9.07M Sell
313,415
-12,418
-4% -$362K 0.26% 68
2024
Q2
$9.12M Sell
325,833
-6,738
-2% -$186K 0.27% 67
2024
Q1
$9.23M Sell
332,571
-25,035
-7% -$695K 0.27% 67
2023
Q4
$10.3M Sell
357,606
-47,558
-12% -$1.44M 0.29% 58
2023
Q3
$13.4M Sell
405,164
-68,739
-15% -$2.43M 0.4% 45
2023
Q2
$17.4M Sell
473,903
-2,610
-0.5% -$102K 0.45% 38
2023
Q1
$19.4M Buy
476,513
+1,971
+0.4% +$85.1K 0.52% 34
2022
Q4
$24.3M Buy
474,542
+6,704
+1% +$321K 0.68% 26
2022
Q3
$20.5M Buy
467,838
+2,208
+0.5% +$107K 0.61% 27
2022
Q2
$24.4M Sell
465,630
-3,026
-0.6% -$154K 0.58% 29
2022
Q1
$24.3M Sell
468,656
-6,282
-1% -$326K 0.47% 37
2021
Q4
$28M Buy
474,938
+7,114
+2% +$352K 0.52% 30
2021
Q3
$20.1M Sell
467,824
-4,272
-0.9% -$189K 0.41% 46
2021
Q2
$18.5M Sell
472,096
-1,039
-0.2% -$40.4K 0.38% 53
2021
Q1
$17.1M Sell
473,135
-14,188
-3% -$504K 0.37% 55
2020
Q4
$17.9M Sell
487,323
-45,779
-9% -$1.68M 0.41% 49
2020
Q3
$18.6M Sell
533,102
-5,282
-1% -$185K 0.45% 42
2020
Q2
$16.7M Sell
538,384
-32,346
-6% -$1.1M 0.43% 48
2020
Q1
$17.7M Sell
570,730
-9,890
-2% -$337K 0.5% 35
2019
Q4
$21.6M Sell
580,620
-28,847
-5% -$1.03M 0.48% 43
2019
Q3
$20.8M Sell
609,467
-7,180
-1% -$261K 0.48% 49
2019
Q2
$25.3M Buy
616,647
+4,953
+0.8% +$197K 0.59% 31
2019
Q1
$24.6M Sell
611,694
-20,670
-3% -$828K 0.59% 32
2018
Q4
$26.2M Buy
632,364
+2,346
+0.4% +$97.4K 0.7% 24
2018
Q3
$26.3M Buy
630,018
+1,609
+0.3% +$61.9K 0.63% 28
2018
Q2
$21.6M Sell
628,409
-8,543
-1% -$292K 0.54% 44
2018
Q1
$21.4M Sell
636,952
-1,968
-0.3% -$67.7K 0.55% 37
2017
Q4
$22M Buy
638,920
+2,106
+0.3% +$71.8K 0.54% 38
2017
Q3
$21.6M Buy
636,814
+2,049
+0.3% +$65.9K 0.56% 35
2017
Q2
$20.2M Buy
634,765
+3,445
+0.5% +$109K 0.53% 41
2017
Q1
$20.5M Sell
631,320
-9,887
-2% -$312K 0.55% 43
2016
Q4
$19.8M Buy
641,207
+7,557
+1% +$231K 0.53% 47
2016
Q3
$20.4M Buy
633,650
+6,043
+1% +$202K 0.55% 41
2016
Q2
$21M Buy
627,607
+7,581
+1% +$242K 0.59% 41
2016
Q1
$17.4M Sell
620,026
-7,296
-1% -$208K 0.5% 47
2015
Q4
$19.2M Buy
627,322
+17,516
+3% +$551K 0.57% 41
2015
Q3
$18.2M Sell
609,806
-3,952
-0.6% -$127K 0.6% 34
2015
Q2
$19.5M Buy
613,758
+11,355
+2% +$370K 0.61% 32
2015
Q1
$19.9M Buy
602,403
+381
+0.1% +$12.1K 0.58% 34
2014
Q4
$17.8M Buy
602,022
+8,561
+1% +$245K 0.55% 41
2014
Q3
$16.6M Sell
593,461
-7,554
-1% -$212K 0.56% 38
2014
Q2
$16.9M Sell
601,015
-1,997
-0.3% -$56.9K 0.57% 39
2014
Q1
$18.4M Sell
603,012
-8,441
-1% -$252K 0.67% 34
2013
Q4
$17.8M Sell
611,453
-12,071
-2% -$351K 0.67% 24
2013
Q3
$17M Buy
623,524
+2,069
+0.3% +$56.3K 0.68% 27
2013
Q2
$16.5M Buy
+621,455
New +$17.2M 0.67% 34

Other funds holding PFE

Securian Asset Management's PFE Position: Q1 2026 in Review

Securian Asset Management reduced its Pfizer (PFE) stake by 0.23% in Q1 2026, selling an estimated $9.61K and leaving 154,244 shares worth $4.33M. The position accounts for 0.17% of the portfolio, ranked #82.

Securian Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $28M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Securian Asset Management held 154,244 shares of Pfizer worth $4.33M as of Q1 2026.
  • Securian Asset Management sold 361 Pfizer shares in Q1 2026, an estimated $9.61K.
  • Pfizer made up 0.17% of Securian Asset Management's portfolio in Q1 2026, its #82 holding.
  • Securian Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Securian Asset Management's Pfizer position peaked at $28M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.